-
公开(公告)号:US20230034320A1
公开(公告)日:2023-02-02
申请号:US17489824
申请日:2021-09-30
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Aviel EVEN , Dan EVEN
IPC: C12N15/82
Abstract: Disclosed herein are genetically modified plants expressing multiple animal milk proteins. Further disclosed are vectors for expressing in a plant and parts thereof, multiple mammalian milk proteins; genetically modified and or gene-edited plants having at least one cell expressing and producing at least two recombinant mammalian milk proteins wherein expression may be in a seed, bean, grain, fruit, nut, legume, leaf, stem, root, or portion thereof, the recombinant protein being produced by the plant cell; and a method of producing a food, medicament, cosmetic or blocking composition from the genetically modified or gene-edited plant. Reduction or elimination of seed storage proteins in a cell or cells wherein the milk proteins are expressed, or reduction of plant enzymes that can increase the content of oleic and/or stearic fatty acids and/or reduce the content of saturated fats in the plants or plant products are also disclosed.
-
公开(公告)号:US20180251801A1
公开(公告)日:2018-09-06
申请号:US15758372
申请日:2016-09-11
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Guy Polturak
IPC: C12P13/22 , A23L3/3544 , A23L5/46 , C07K14/415 , C12N9/12 , C12N9/02 , C12P17/12 , C12P19/02
CPC classification number: C12P13/225 , A23L3/3463 , A23L3/3526 , A23L3/3544 , A23L5/46 , A23V2002/00 , C07K14/415 , C12N9/0083 , C12N9/1205 , C12P13/04 , C12P17/12 , C12P19/02 , C12Y207/01095 , A23V2200/044
Abstract: The invention provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD6 or related gene and their use for producing L-DOPA from tyrosine and treating dopamine-responsive disorders, such as Parkinson's Disease. The invention also provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD1 and/or CYP76AD6, a nucleic acid encoding a DOPA 4,5-dioxygenase (DOD) enzyme, such as Beta vulgaris DODA1, and, in some cases, a nucleic acid encoding betalain related glucosyltransferase, such as M. jalapa gene cyclo-DOPA 5-O-glucosyltransferase (cDOPA5GT), and their use for producing betalains. Finally, the invention provides chimeric polypeptides, expression vectors, cells, compositions, and organisms, including plants, and their uses in various methods of the invention.
-
公开(公告)号:US20240263202A1
公开(公告)日:2024-08-08
申请号:US18436233
申请日:2024-02-08
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Guy POLTURAK
IPC: C12P13/22 , A23L3/3463 , A23L3/3526 , A23L3/3544 , A23L5/46 , C07K14/415 , C12N9/02 , C12N9/12 , C12P13/04 , C12P17/12 , C12P19/02
CPC classification number: C12P13/225 , A23L3/3463 , A23L3/3526 , A23L3/3544 , A23L5/46 , C07K14/415 , C12N9/0083 , C12N9/1205 , C12P13/04 , C12P17/12 , C12P19/02 , C12Y207/01095 , A23V2002/00
Abstract: The invention provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD6 or related gene and their use for producing L-DOPA from tyrosine and treating dopamine-responsive disorders, such as Parkinson's Disease. The invention also provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD1 and/or CYP76AD6, a nucleic acid encoding a DOPA 4,5-dioxygenase (DOD) enzyme, such as Beta vulgaris DODA1, and, in some cases, a nucleic acid encoding betalain related glucosyltransferase, such as M. jalapa gene cyclo-DOPA 5-O-glucosyltransferase (cDOPA5GT), and their use for producing betalains. Finally, the invention provides chimeric polypeptides, expression vectors, cells, compositions, and organisms, including plants, and their uses in various methods of the invention.
-
公开(公告)号:US20220217934A1
公开(公告)日:2022-07-14
申请号:US17272685
申请日:2019-09-05
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Prashant SONAWANE , Maxim ITKIN , Adam JOZWlAK
Abstract: Provided herein are genetically modified cells and genetically modified plants having increased or decreased expression of a cellulose synthase like G (CSLG) enzyme. These cells and plants may have an increased or decreased content a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin, compared to a corresponding unmodified cell or plant. Also provided herein are methods of producing a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin in a genetically modified cell, as well as methods of reducing the content of a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin in a cell of a plant or a plant part, and methods of increasing the content of a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin in a cell of a plant or a plant part.
-
公开(公告)号:US20200367493A1
公开(公告)日:2020-11-26
申请号:US16323787
申请日:2017-06-06
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Ilana KOLODKIN-GAL , Asaph AHARONI
Abstract: The present invention relates to the identification and use of natural plant compounds for inducing, enhancing and maintaining beneficial rhizobacteria biofilm formation on a plant or plant part thereof, and conversely, inhibiting formation of biofilms and pellicle by plant pathogens. Methods of use for stimulating matrix production from the beneficial rhizobacteria and enhanced adhesion of the rhizobacteria to a plant or plant part thereof are also described. Methods of use for inhibition plant pathogen adhesion to biofilms are also described.
-
公开(公告)号:US20240182873A1
公开(公告)日:2024-06-06
申请号:US18281536
申请日:2022-03-10
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Prashant SONAWANE , Adam JOZWIAK , Paula BERMAN , Luis DE-HARO
CPC classification number: C12N9/1085 , C12P7/42
Abstract: The present invention provides polynucleotide sequences derived from Helichrysum umbraculigerum and encoding a protein or a plurality thereof belonging to the prenyltransferase (PT) family. Further provided are an artificial nucleic acid molecule including the polynucleotide, a transgenic cell, tissue, or plant including same.
-
公开(公告)号:US20220408679A1
公开(公告)日:2022-12-29
申请号:US17859053
申请日:2022-07-07
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Prashant SONAWANE , Maxim ITKIN
Abstract: The present invention relates to key genes in the biosynthesis of steroidal alkaloids and saponins, including regulatory genes and enzyme-encoding genes, and to use thereof for altering the content of steroidal (glyco)alkaloids or phytosterols in plants. The present invention provides genetically modified plants or gene edited plants with altered content of steroidal (glyco)alkaloids, particularly to Solanaceous crop plants with reduced content of antinutritional steroidal glycoalkaloids and to the increase in phytosterols, including cholesterol or cholestanol in these plants. The present invention also provides methods of altering gene expression.
-
8.
公开(公告)号:US20160122775A1
公开(公告)日:2016-05-05
申请号:US14895059
申请日:2014-06-02
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Asaph AHARONI , Maxim ITKIN
IPC: C12N15/82
CPC classification number: C12N15/8218 , C12N15/8243 , C12N15/8247
Abstract: The present invention relates to genetically modified plants by key genes involved in the biosynthesis of steroidal alkaloids. These plants have altered content of steroidal (glyco)alkaloids. Solanaceous crop plants with reduced content of antinutritional steroidal glycoalkaloids are provided.
Abstract translation: 本发明涉及通过涉及甾体生物碱生物合成的关键基因的遗传修饰植物。 这些植物改变了类固醇(glyco)生物碱的含量。 提供了抗营养型甾体生物碱含量降低的茄科作物。
-
公开(公告)号:US20250092415A1
公开(公告)日:2025-03-20
申请号:US18910862
申请日:2024-10-09
Applicant: Yeda Research and Development Co. Ltd. , Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
Inventor: Asaph AHARONI , Prashant SONAWANE , Pablo D. CARDENAS , Saul BURDMAN
Abstract: Disclosed herein are genetically modified plants having altered biological activity of 3-β-hydroxysteroid dehydrogenase/isomerase (GAME25), or 2-oxoglutarate-dependent dioxygenase (GAME31), or a combination thereof, wherein the genetically modified plants have an altered content of at least one cholesterol derived compound selected from the group including a steroidal alkaloid or a glycosylated derivative thereof and an unsaturated or saturated steroidal saponin or a glycoside derivative thereof. Further disclosed herein are genetically modified plants having altered expression of a gene encoding a 3-β-hydroxysteroid dehydrogenase/isomerase (GAME25), or a 2-oxoglutarate-dependent dioxygenase (GAME31), or a combination thereof, wherein the genetically modified plant has an altered content of at least one cholesterol derived compound selected from the group including a steroidal alkaloid or a glycosylated derivative thereof and an unsaturated or saturated steroidal saponin or a glycoside derivative thereof. Methods of producing these genetically modified plants are also disclosed.
-
公开(公告)号:US20240315192A1
公开(公告)日:2024-09-26
申请号:US18735258
申请日:2024-06-06
Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Inventor: Asaph AHARONI , Prashant SONAWANE , Maxim ITKIN , Adam JOZWIAK
CPC classification number: A01H6/82 , C12N9/1059 , C12N15/8218 , C12N15/8243 , C12N15/8247
Abstract: Provided herein are genetically modified cells and genetically modified plants having increased or decreased expression of a cellulose synthase like G (CSLG) enzyme. These cells and plants may have an increased or decreased content a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin, compared to a corresponding unmodified cell or plant. Also provided herein are methods of producing a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin in a genetically modified cell, as well as methods of reducing the content of a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin in a cell of a plant or a plant part, and methods of increasing the content of a steroidal alkaloid, a steroidal saponin, or a triterpenoid saponin in a cell of a plant or a plant part.
-
-
-
-
-
-
-
-
-